IART R&D Expenses
Integra Lifesciences Holdings Corp · R&D Expenses

IART R&D Expenses
Latest reported$24.25Mperiod ending
IART Quarterly R&D Expenses ($0.00 → $24.25M)
Quarterly R&D Expenses
High-resolution chart · PNG
IART r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 24,253,000 | |
| 23,501,000 | |
| 24,791,000 | |
| 22,456,000 | |
| 26,997,000 | |
| 24,728,000 | |
| 31,210,000 | |
| 27,435,000 | |
| 29,767,000 | |
| 26,965,000 | |
| 24,284,000 | |
| 26,596,000 | |
| 26,588,000 | |
| 26,724,000 | |
| 26,783,000 | |
| 24,736,000 | |
| 25,589,000 | |
| 24,085,000 | |
| 24,725,000 | |
| 25,831,000 | |
| 20,121,000 | |
| 22,374,000 | |
| 22,179,000 | |
| 19,460,000 | |
| 14,926,000 | |
| 20,816,000 | |
| 26,293,000 | |
| 19,003,000 | |
| 17,633,000 | |
| 18,321,000 | |
| 20,299,000 | |
| 20,309,000 | |
| 19,108,000 | |
| 18,325,000 | |
| 17,180,000 | |
| 15,034,000 | |
| 15,747,000 | |
| 15,494,000 | |
| 13,901,000 | |
| 15,124,000 | |
| 14,679,000 | |
| 14,451,000 | |
| 13,866,000 | |
| 13,938,000 | |
| 13,891,000 | |
| 12,556,000 | |
| 12,157,000 | |
| 13,127,000 | |
| 13,745,000 | |
| 12,567,000 | |
| 14,511,000 | |
| 13,052,000 | |
| 11,809,000 | |
| 12,716,000 | |
| 12,864,000 | |
| 13,105,000 | |
| 13,131,000 | |
| 11,912,000 | |
| 13,402,000 | |
| 13,187,000 | |
| 12,709,000 | |
| 12,153,000 | |
| 13,331,000 | |
| 11,721,000 | |
| 11,761,000 | |
| 11,301,000 | |
| 11,810,000 | |
| 11,525,000 | |
| 10,302,000 | |
| 10,643,000 | |
| 10,186,000 | |
| 34,718,000 | |
| 7,793,000 | |
| 7,798,000 | |
| 11,813,000 | |
| 6,546,000 | |
| 6,239,000 | |
| 6,060,000 | |
| 5,214,000 | |
| 10,991,000 | |
| 6,354,000 | |
| 3,173,000 | |
| 2,704,000 | |
| 3,110,000 | |
| 2,787,000 | |
| 3,359,000 | |
| 3,556,000 | |
| 5,103,000 | |
| 2,639,000 | |
| 2,823,000 | |
| 4,771,000 | |
| 2,616,000 | |
| 2,777,000 | |
| 2,650,000 | |
| 2,249,000 | |
| 2,160,000 | |
| 2,073,000 | |
| 1,822,000 | |
| 1,910,000 | |
| 2,172,000 |